Wang, Z., Liu, C., Bai, Y., Zhao, X., Cui, L., Peng, Z., . . . Shen, L. (2021). Redefine Hyperprogressive Disease During Treatment With Immune-Checkpoint Inhibitors in Patients With Gastrointestinal Cancer. Frontiers Media S.A.
Chicago Style (17th ed.) CitationWang, Zhenghang, et al. Redefine Hyperprogressive Disease During Treatment With Immune-Checkpoint Inhibitors in Patients With Gastrointestinal Cancer. Frontiers Media S.A, 2021.
MLA (8th ed.) CitationWang, Zhenghang, et al. Redefine Hyperprogressive Disease During Treatment With Immune-Checkpoint Inhibitors in Patients With Gastrointestinal Cancer. Frontiers Media S.A, 2021.
Warning: These citations may not always be 100% accurate.